Is Zofran (Ondansetron) Safe During Pregnancy?
Yes, ondansetron is safe to use during pregnancy and should be used as a second-line antiemetic when first-line medications fail to control nausea and vomiting. 1
Evidence-Based Recommendation
The most recent 2024 BJOG guideline from the Royal College of Obstetricians and Gynaecologists explicitly states that ondansetron is both safe and effective, and its use should not be discouraged when first-line antiemetics are ineffective 1. This represents the highest quality guidance available and directly addresses the safety concern.
Treatment Algorithm
First-line options (try these first):
- Antihistamines (H1 blockers)
- Phenothiazines
- Doxylamine/pyridoxine combinations 1
Second-line option (when first-line fails):
- Ondansetron - use without hesitation if needed 1
The Orofacial Cleft Concern - Putting Risk in Perspective
Women can be reassured about the very small absolute increase in orofacial clefting risk with first-trimester ondansetron use 1. This is critical context: while some studies have identified a statistical association, the absolute risk increase is minimal and must be balanced against the significant risks of poorly managed hyperemesis gravidarum, including:
- Severe dehydration
- Electrolyte imbalances
- Weight loss
- Nutritional deficiencies
- Maternal morbidity
The 2024 guideline emphasizes that this tiny theoretical risk should not prevent ondansetron use when clinically indicated 1.
Supporting Safety Data
The FDA labeling classifies ondansetron as Pregnancy Category B, meaning animal reproduction studies showed no fetal harm at doses up to 15-30 mg/kg/day in rats and rabbits 2. However, the label notes that "adequate and well-controlled studies in pregnant women" are lacking, which is why clinical judgment matters.
Large-scale human studies support safety:
- A multinational cohort of 456,963 pregnancies found no association between ondansetron and fetal death, spontaneous abortion, stillbirth, or major congenital malformations compared to other antiemetics 3
- A Danish cohort of 608,385 pregnancies similarly found no significantly increased risk of adverse fetal outcomes 4
- A 2026 scoping review concluded ondansetron "likely poses low risk of harm to maternal and neonatal health" 5
Important Caveats
One emerging concern: A 2025 study suggests ondansetron may be associated with increased urinary tract infection risk during pregnancy 6. Monitor for UTI symptoms in pregnant patients taking ondansetron, though this finding requires confirmation.
Contraindication: Never use ondansetron with apomorphine due to risk of profound hypotension and loss of consciousness 2.
Clinical Bottom Line
When nausea and vomiting of pregnancy fails to respond to first-line antiemetics, prescribe ondansetron confidently. The benefits of controlling severe nausea and vomiting far outweigh the minimal theoretical risks. The 2024 guideline's Grade B recommendation reflects solid evidence supporting both safety and efficacy 1.